Insufficient scRNA-seq data for expression of HTR1D at single-cell level.
Insufficient scRNA-seq data for expression of HTR1D at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 52% | 80.70 | 500 / 966 | 87% | 10.95 | 461 / 527 |
lung | 66% | 24.60 | 384 / 578 | 47% | 3.72 | 538 / 1155 |
brain | 80% | 200.75 | 2105 / 2642 | 29% | 1.06 | 202 / 705 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.26 | 1 / 1 |
pancreas | 13% | 4.71 | 44 / 328 | 84% | 7.61 | 150 / 178 |
bladder | 43% | 24.00 | 9 / 21 | 53% | 4.44 | 269 / 504 |
stomach | 3% | 0.45 | 11 / 359 | 79% | 9.84 | 225 / 286 |
prostate | 55% | 21.11 | 134 / 245 | 7% | 0.11 | 33 / 502 |
esophagus | 5% | 1.14 | 68 / 1445 | 53% | 5.31 | 97 / 183 |
uterus | 18% | 4.34 | 31 / 170 | 37% | 2.09 | 168 / 459 |
breast | 13% | 3.18 | 59 / 459 | 40% | 1.45 | 443 / 1118 |
liver | 4% | 0.77 | 10 / 226 | 30% | 3.16 | 121 / 406 |
ovary | 11% | 1.62 | 19 / 180 | 7% | 0.13 | 30 / 430 |
spleen | 17% | 3.86 | 41 / 241 | 0% | 0 | 0 / 0 |
kidney | 10% | 2.11 | 9 / 89 | 6% | 0.33 | 54 / 901 |
skin | 8% | 1.24 | 138 / 1809 | 8% | 0.28 | 36 / 472 |
thymus | 6% | 0.96 | 41 / 653 | 8% | 0.18 | 51 / 605 |
adrenal gland | 9% | 1.88 | 23 / 258 | 4% | 0.34 | 10 / 230 |
adipose | 7% | 1.62 | 88 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.14 | 3 / 45 |
heart | 6% | 0.82 | 50 / 861 | 0% | 0 | 0 / 0 |
muscle | 3% | 0.49 | 28 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 0.65 | 32 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 0.24 | 23 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007198 | Biological process | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO_0014827 | Biological process | intestine smooth muscle contraction |
GO_0050795 | Biological process | regulation of behavior |
GO_0042310 | Biological process | vasoconstriction |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0040012 | Biological process | regulation of locomotion |
GO_0007187 | Biological process | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO_0030425 | Cellular component | dendrite |
GO_0045202 | Cellular component | synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0004993 | Molecular function | G protein-coupled serotonin receptor activity |
GO_0030594 | Molecular function | neurotransmitter receptor activity |
Gene name | HTR1D |
Protein name | 5-hydroxytryptamine receptor 1D (5-HT-1D) (5-HT1D) (Serotonin 1D alpha receptor) (5-HT-1D-alpha) (Serotonin receptor 1D) |
Synonyms | HTR1DA HTRL |
Description | FUNCTION: G-protein coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for ergot alkaloid derivatives, various anxiolytic and antidepressant drugs and other psychoactive substances. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity. Regulates the release of 5-hydroxytryptamine in the brain, and thereby affects neural activity. May also play a role in regulating the release of other neurotransmitters. May play a role in vasoconstriction. . |
Accessions | ENST00000374619.2 P28221 |